Form 4: Candel Therapeutics Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
William Garrett Nichols, Chief Medical Officer of Candel Therapeutics, sold 10,799 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On January 8, 2025, William Garrett Nichols, the Chief Medical Officer of Candel Therapeutics, sold 10,799 shares of common stock.
- The sale was executed at a price of $8.2183 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as per the issuer's mandatory sell-to-cover policy.
- Following the transaction, Nichols directly owns 89,748 shares of Candel Therapeutics stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees.
Key Dates
| Date | Description |
|---|---|
| 01/08/2025 | Date of stock sale transaction |
| 01/10/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.